Jacquelyn Sumer
Compliance Officer bei CULLINAN THERAPEUTICS, INC.
Vermögen: 2 Mio $ am 30.04.2024
Aktive Positionen von Jacquelyn Sumer
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| CULLINAN THERAPEUTICS, INC. | Compliance Officer | 15.08.2022 | - |
| General Counsel | 15.08.2022 | - | |
| Unternehmenssekretär | 15.08.2022 | - |
Karriereverlauf von Jacquelyn Sumer
Ehemalige bekannte Positionen von Jacquelyn Sumer
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| CELGENE | Direktor/Vorstandsmitglied | 01.05.2017 | 01.07.2018 |
| Corporate Officer/Principal | 01.05.2017 | 01.07.2018 | |
| BRISTOL-MYERS SQUIBB COMPANY | Corporate Officer/Principal | - | - |
| GENOCEA BIOSCIENCES, INC. | Compliance Officer | 01.02.2021 | - |
| General Counsel | 01.02.2021 | - |
Ausbildung von Jacquelyn Sumer
| Duke University School of Law | Graduate Degree |
| Bucknell University | Undergraduate Degree |
Statistik
International
| Vereinigte Staaten | 7 |
Operativ
| Compliance Officer | 2 |
| General Counsel | 2 |
| Corporate Officer/Principal | 2 |
Sektoral
| Health Technology | 5 |
| Consumer Services | 3 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 3 |
|---|---|
| GENOCEA BIOSCIENCES, INC. | Health Technology |
| BRISTOL-MYERS SQUIBB COMPANY | Health Technology |
| CULLINAN THERAPEUTICS, INC. | Health Technology |
| Private Unternehmen | 1 |
|---|---|
Celgene Corp.
 Celgene Corp. BiotechnologyHealth Technology Celgene Corp. is an integrated global biopharmaceutical company, which engages in the discovery, development and commercialization of therapies for the treatment of cancer and inflammatory diseases. Its primary commercial stage products include Revlimid, Pomalyst, Imnovid, Otezla, Abraxane, and Vidaza. The company was founded by David Stirling and Sol Barer in 1986 and is headquartered in Summit, NJ. | Health Technology |
- Börse
- Insiders
- Jacquelyn Sumer
- Erfahrung
